Chinese guidelines for HER2 testing in breast cancer (2024 edition): summary of key recommendations
{{output}}
In December 2024, the Chinese expert panel released the updated Chinese Guidelines for human epidermal growth factor receptor 2 (HER2) testing in breast cancer (2024 edition), building on the 2019 version and incorporating recent advancements. These guidelines... ...
